Novel HARS2 missense variants identified in individuals with sensorineural hearing impairment and Perrault syndrome |
| |
Affiliation: | 1. Melbourne Law School, University of Melbourne, Carlton, Australia;2. Murdoch Children''s Research Institute, The Royal Children''s Hospital, Parkville, Australia;3. Center for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Belgium;4. Leuven Institute for Human Genetics and Society, Leuven, Belgium;5. Centre of Genomics and Policy, McGill University, Montreal, Canada |
| |
Abstract: | Biallelic variants in HARS2 have been associated with Perrault syndrome, characterized by sensorineural hearing impairment and premature ovarian insufficiency. Here we report three novel families, compound heterozygous for missense variants in HARS2 identified by next-generation sequencing, namely c.172A > G (p.Lys58Glu) and c.448C > T (p.Arg150Cys) identified in two sisters aged 13 and 16 years and their older brother, c.448C > T (p.Arg150Cys) and c.980G > A (p.Arg327Gln) identified in a seven year old girl, and finally c.137T > A (p.Leu46Gln) and c.259C > T (p.Arg87Cys) identified in a 32 year old woman. Clinically, all five individuals presented with early onset, rapidly progressive hearing impairment. Whereas the oldest female fulfilled the criteria of Perrault syndrome, the three younger females, aged 7, 13 and 16, all had apparently normal ovarian function, apart from irregular menstrual periods in the oldest female at age 16. The present report expands the list of HARS2 variants and helps gain further knowledge to the phenotype. |
| |
Keywords: | Sensorineural hearing impairment Next-generation sequencing Perrault syndrome Premature ovarian insufficiency |
本文献已被 ScienceDirect 等数据库收录! |
|